TSP320-DrugMatrix - Toxicogenomic signatures after exposure to phenytoin in the rat


TSA1236-DrugMatrix - Toxicogenomic signatures of Heart after exposure to phenytoin (572 mg/kg, 3 days) in the rat


TSA1237-DrugMatrix - Toxicogenomic signatures of Heart after exposure to phenytoin (572 mg/kg, 5 days) in the rat


TSA1238-DrugMatrix - Toxicogenomic signatures of Skeletal muscle tissue after exposure to phenytoin (572 mg/kg, 3 days) in the rat


TSA1239-DrugMatrix - Toxicogenomic signatures of Skeletal muscle tissue after exposure to phenytoin (572 mg/kg, 5 days) in the rat


TSF1236-phenytoin


1 subfactor(s)
TSF1237-phenytoin


1 subfactor(s)
TSF1238-phenytoin


1 subfactor(s)
TSF1239-phenytoin


1 subfactor(s)
TSS1236-DrugMatrix - Toxicogenomic signatures of Heart after exposure to phenytoin (572 mg/kg, 3 days) in the rat


TSS1237-DrugMatrix - Toxicogenomic signatures of Heart after exposure to phenytoin (572 mg/kg, 5 days) in the rat


TSS1238-DrugMatrix - Toxicogenomic signatures of Skeletal muscle tissue after exposure to phenytoin (572 mg/kg, 3 days) in the rat


TSS1239-DrugMatrix - Toxicogenomic signatures of Skeletal muscle tissue after exposure to phenytoin (572 mg/kg, 5 days) in the rat



TSP320 - DrugMatrix - Toxicogenomic signatures after exposure to phenytoin in the rat Public


DrugMatrix is the scientific communities' largest molecular toxicology reference database and informatics system. DrugMatrix is populated with the comprehensive results of thousands of highly controlled and standardized toxicological experiments in which rats or primary rat hepatocytes were systematically treated with therapeutic, industrial, and environmental chemicals at both non-toxic and toxic doses.

Interventional Experimental design


No experimental design provided

Results


No results provided